Research Center on Managed Care and Drug Abuse Treatment

描述（由申请人提供）： 在这一修订后的更新要求布兰代斯/哈佛中心管理式医疗和药物滥用治疗，我们建议继续合作之间的布兰代斯大学的施耐德研究所卫生政策和哈佛医学院的卫生保健政策部门。我们建议该中心继续保持基本相同的多学科研究小组。我们通过中心核心扩大了临床、统计和方法学专业知识，并强调技术转让是核心职能。我们建议完善该中心的主题，从一个通用的重点管理式医疗的第二代研究，探讨这个问题：什么样的组织，管理，融资和支付管理式医疗环境中的元素，使有效的药物滥用服务提供的差异？特别是，如何利用这些领域内的激励措施来鼓励或支持提供高质量的药物滥用治疗服务？围绕这一主题，我们计划了两个项目和一个试点项目，简述如下： 员工群体的物质滥用途径。该研究将使用来自管理健康网络（MI-IN）的索赔资格，授权和初步评估数据，以调查综合EAP/MBHC和独立组件产品之间的药物滥用利用和成本是否存在差异。还将对通过MHN接受药物滥用治疗的使用者和非使用者进行调查。 行为卫生保健中的剖析和激励。这项研究评估了提供者分析和激励措施对提高护理质量的贡献。结合准实验中断的时间序列和随机对照设计，该研究使用现有的数据，从低收入的一般援助客户谁接受药物滥用治疗的康涅狄格州的管理行为卫生保健计划。 试点：平等立法对药物滥用治疗的影响。该试点项目将探讨在加州的私人健康保险中增加药物滥用治疗同等福利的增量影响的大规模研究的可行性。

DESCRIPTION (provided by applicant): In this revised renewal request for the Brandeis / Harvard Center on Managed Care and Drug Abuse Treatment, we propose to continue the collaboration between Brandeis University's Schneider Institute for Health Policy and Harvard Medical School's Department of Health Care Policy. We propose that the Center continue with largely the same multidisciplinary group of researchers. We have expanded the clinical, statistical, and methodological expertise available through the Center Core, as well as our emphasis on technology transfer as a core function. We propose to refine the Center's theme from a generic focus on managed care to a second generation of studies that examine the question: What elements of organization, management, financing and payment in a managed care environment make a difference in effective drug abuse service delivery? In particular, how can incentives within these areas be used to encourage or support the provision of quality drug abuse treatment services? With this theme we have planned two projects and a pilot described briefly below: Substance Abuse Pathways for Employee Groups. The study will use claims eligibility, authorization, and initial assessment data from Managed Health Network (MI-IN) to investigate whether there are differences in substance abuse utilization and costs between integrated EAP/MBHC and stand-alone component products. A survey of enrollees who are both users and nonusers of substance abuse treatment through MHN will also be conducted. Profiling and Incentives in Behavioral Health Care. This research evaluates the contribution of provider profiling and incentives to improve the quality of care. Combining a quasi-experimental interrupted time series and randomized-controlled designs, the study uses existing data from low-income general assistance clients who receive substance abuse treatment under the state of Connecticut's managed behavioral health care program. Pilot: The Effect of Parity Legislation on Substance Abuse Treatment. This pilot will explore the feasibility for a large-scale study of the incremental impact of adding a substance abuse treatment parity benefit to private health insurance in California.